A summary of <i>katakori</i> patient backgrounds.

<p>A summary of <i>katakori</i> patient backgrounds, findings at each acupuncture point (presence or absence of PTs or TrPs), response during MAPI (presence or absence of an LTR), extent of symptom improvement after MAPI (PRS), and duration (days) of symptom improvement after MAPI. The acupuncture names in the table are written based on the WHO notations.</p><p>Abbreviations: PT tender point, TrP trigger point, LTR local twitch response, MAPI multi-acupuncture point injection</p><p>A summary of <i>katakori</i> patient backgrounds.</p

Photographs (a-e) and schematic illustrations (f-j) of the injection sites in BL-10 (a and f), GB-21 (b and g), LI-16 (c and h), SI-14 (d and i), and BL-38 (e and j) in a cadaver.

<p>Arrows and arrowheads indicate the suprascapular artery and nerve, respectively. Tr: Fascia of trapezius, Sc: Fascia of semispinalis capitis, Rma: Fascia of rectus capitis posterior major, Rmi: Fascia of rectus capitis posterior minor, Su: Fascia of supraspinatus, Rh: Fascia of rhomboid, Sca: Bone of scapula.</p

Schema of the injection sites for BL-10, GB-21, LI-16, SI-14, and BL-38.

<p>The red circles in the figure show the acupuncture point sites as follows: BL-21, outer margin of the suboccipital trapezius muscle; GB-21, midpoint of the transverse process of the seventh cervical vertebra (C7) and the outer margin of the acromion; LI-16, the outer margin of the supraspinatous fossa; SI-14, medial side of the superior angle of the scapula; and BL-38, medial margin midpoint of the scapula.</p

The muscles and nerves that are related to acupuncture points.

<p>Summarizes deeply-dyed sites of acupuncture point injection in cadavers.</p><p>Deep dyeing was observed in each muscle; nerves innervating the muscles are shown, as are the origin levels of the innervating nerves.</p><p>The muscles and nerves that are related to acupuncture points.</p

Receiver operating characteristic curve analysis using serum microRNAs ((A) miR-7, (B) miR-34a, (C) miR-181d, (D) miR-193b) for distinguishing PDAC from AIP.

<p>Receiver operating characteristic curve analysis using serum microRNAs ((A) miR-7, (B) miR-34a, (C) miR-181d, (D) miR-193b) for distinguishing PDAC from AIP.</p

Serum expression of miRNAs in patients with pancreatic diseases.

<p>Scatter plots of serum miRNA expression in AIP (n = 15), IPMN (n = 26) and PDAC patients (n = 69). The Y-axis represents the relative expression of the miRNAs normalized to cel-miR-39. The line represents the median value. The significance of differences was determined using Mann-Whitney test (***P < .001: **P < .01). (A) miR-7 expression. (B) miR-34a expression. (C) miR-181d expression. (D) miR-193b expression. AIP, autoimmune pancreatitis; IPMN, intraductal papillary mucinous neoplasm; PDAC, pancreatic ductal adenocarcinoma.</p

Serum miRNA expression in PDAC at different Tumor Node Metastasis (TNM) stages.

<p>The Y-axis (log₁₀ scale) represents the relative expression of each miRNA normalized to cel-miR-39. Boxes represent the interquartile range, and the horizontal line across each box indicates the median value. The significance of differences was determined using Mann-Whitney test (**P < .01: *P < .05). (A) miR-7 expression. (B) miR-34a expression. (C) miR-181d expression. (D) miR-193b expression. PDAC, pancreatic ductal adenocarcinoma; AIP, autoimmune pancreatitis.</p